Yahoo
NasdaqCM - BOATS Real Time Price USD

Nuvectis Pharma, Inc. (NVCT)

18.48 -0.09 (-0.48%)
At close: October 30 at 4:00:01 PM EDT
19.58 +1.10 (+5.95%)
Overnight: 9:30:40 PM EST
Trade NVCT on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
28,868
27,574
19,847
22,897
19,234
Operating Income
-28,868
-27,574
-19,847
-22,897
-19,234
Net Non Operating Interest Income Expense
1,022
1,132
847
637
149
Pretax Income
-27,846
-26,442
-19,000
-22,260
-19,085
Net Income Common Stockholders
-30,275
-28,871
-19,000
-22,260
-19,085
Diluted NI Available to Com Stockholders
-30,275
-28,871
-19,000
-22,260
-19,085
Basic EPS
-1.32
-1.32
-1.11
-1.43
-1.51
Diluted EPS
-1.32
-1.32
-1.11
-1.43
-1.51
Basic Average Shares
23,207.49
21,812.72
17,113.17
15,556.66
12,657.65
Diluted Average Shares
23,207.49
21,812.72
17,113.17
15,556.66
12,657.65
Total Operating Income as Reported
-28,868
-27,574
-19,847
-22,897
-19,234
Total Expenses
28,868
27,574
19,847
22,897
19,234
Net Income from Continuing & Discontinued Operation
-27,846
-26,442
-19,000
-22,260
-19,085
Normalized Income
-27,846
-26,442
-19,000
-22,260
-19,085
Interest Income
1,022
1,132
847
637
149
Net Interest Income
1,022
1,132
847
637
149
EBIT
-28,868
-27,574
-19,847
-22,897
-19,234
EBITDA
-28,868
-27,574
-19,847
-22,897
-19,234
Net Income from Continuing Operation Net Minority Interest
-27,846
-26,442
-19,000
-22,260
-19,085
Normalized EBITDA
-28,868
-27,574
-19,847
-22,897
-19,234
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 2/4/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: